Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

E171 - The PsychopharmaStahlogy Show: Don’t Guess! Measure: The Clinical Use of Antipsychotic Plasma Levels

E171 - The PsychopharmaStahlogy Show: Don’t Guess! Measure: The Clinical Use of Antipsychotic Plasma Levels

FromNEI Podcast


E171 - The PsychopharmaStahlogy Show: Don’t Guess! Measure: The Clinical Use of Antipsychotic Plasma Levels

FromNEI Podcast

ratings:
Length:
56 minutes
Released:
Dec 21, 2022
Format:
Podcast episode

Description

Why is measurement-based care so important to the overall treatment of schizophrenia? What are the most important reasons for using plasma antipsychotic levels when treating schizophrenia patients?   In this episode, Dr. Andrew Cutler interviews Dr. Jonathan Meyer about the importance of measuring plasma levels when administering antipsychotics.   With this special series, brought to you by the NEI Podcast we will address a different theme in psychopharmacology every 3 months. Each theme is split into 3 parts, with one part released each month. This theme is on complex treatment-resistant psychotic disorders.  Episodes to be released under this theme include:  Part 1: Management of Complex Treatment-Resistant Psychotic Disorders with Dr. Michael Cummings  Part 2: The Clozapine Handbook with Dr. Jonathan Meyer  Part 3: Don’t Guess! Measure: The Clinical Use of Antipsychotic Plasma Levels with Dr. Jonathan Meyer  Subscribe to the NEI Podcast, so that you don’t miss another episode! 
Released:
Dec 21, 2022
Format:
Podcast episode

Titles in the series (100)

The Neuroscience Education Institute (NEI) is committed to help raise the standard of mental health by providing imaginative medical education that focuses on the highest level of learning. Each episode offers an opportunity to learn about current issues in psychiatry from key opinion leaders in the medical field. NEI's Podcast would be of value to anyone with an interest in neuropsychiatric diseases and psychopharmacology.